• MELD score determines DAAs' cost-effectiveness pre- or post-transplant

    6 days ago - By Healio

    Direct-acting antiviral treatment in patients with hepatitis C and cirrhosis was most cost-effective and cost-saving pre-liver transplant among those with a MELD score of 21 or less, but post-liver transplant among those with a MELD score over 21, according to a recent study.“The decision to treat HCV pre-LT versus post-LT, needs to balance the benefits and potential harms of HCV treatment in patients on the LT waiting list. In addition, such trade-offs need to factor-in the cost-effectiveness and value of pre-LT versus post-LT HCV treatment,” the researchers wrote.
    Read more ...